Dermatology · Nashville, TN
NPI
1942210877
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
719 Thompson Ln, Suite 26300
Nashville, TN, 37204
Phone (615) 322-6485
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
2,798 services
Medicare patients, 2024
499
Average age 75
Drug cost, 2024
$1.5M
1,026 prescriptions
Company payments, 2025
$3,410
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John A Zic was code 17003 (destruction skin lesion), 1,066 times for 198 patients. In total John A Zic billed 2,798 services in 45 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,066 | 198 | $1.46 | $1,561 |
| 99213 Office E&M - Established | Office | 319 | 255 | $43.93 | $14K |
| 17000 Destruction Skin Lesion | Office | 298 | 233 | $32.51 | $9,688 |
| 99214 Office E&M - Established | Office | 263 | 217 | $64.54 | $17K |
| 11102 Skin Biopsy | Office | 185 | 155 | $19.36 | $3,581 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 137 | 116 | $12.93 | $1,771 |
| 11103 Skin Biopsy | Office | 137 | 75 | $16.22 | $2,223 |
| 17110 Destruction Skin Lesion | Office | 109 | 100 | $43.54 | $4,745 |
| 99215 Office E&M - Established | Office | 86 | 72 | $98.94 | $8,509 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 32 | 12 | $24.16 | $773 |
| 99212 Office E&M - Established | Office | 21 | 20 | $26.17 | $550 |
| 17004 Destruction Skin Lesion | Office | 20 | 18 | $61.56 | $1,231 |
| 12032 Wound Repair - All Levels | Office | 15 | 15 | $136.68 | $2,050 |
| 69100 Other Organ Systems | Office | 14 | 14 | $24.24 | $339 |
| 11104 Skin Biopsy | Office | 13 | 12 | $24.82 | $323 |
By year: 2022 $72K for 2,874 services; 2023 $73K for 2,846 services; 2024 $73K for 2,798 services.
Medicare prescription drug claims, 2024
In 2024, the drug John A Zic prescribed most often to Medicare patients was Bexarotene, with 170 prescriptions and refills. In total John A Zic wrote 1,026 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Bexarotene Generic | 170 | 170 | 21 | $574K |
| Ketoconazole Generic | 97 | 107 | 46 | $1,650 |
| Triamcinolone Acetonide Generic | 93 | 110 | 56 | $858 |
| Mupirocin Generic | 61 | 65 | 38 | $648 |
| Methotrexate Methotrexate Sodium | 50 | 117 | 16 | $939 |
| Clobetasol Propionate Generic | 40 | 43 | 20 | $1,166 |
| Fluocinonide Generic | 38 | 41 | 24 | $1,625 |
| Hydrocortisone Generic | 37 | 39 | 24 | $299 |
| Levothyroxine Sodium Generic | 28 | 77 | Under 11 | $301 |
| Calcipotriene Generic | 27 | 27 | 12 | $3,460 |
| Dupixent Pen Dupilumab | 24 | 28 | Under 11 | $143K |
| Fluorouracil Generic | 23 | 23 | 19 | $1,767 |
| Gabapentin Generic | 20 | 35 | Under 11 | $243 |
| Metronidazole Generic | 17 | 17 | Under 11 | $826 |
| Tacrolimus Generic | 17 | 18 | Under 11 | $1,360 |
Brand drugs: 154 claims; generic drugs: 872 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John A Zic $3,410 ($3,410 in general payments such as food, travel and fees) from 1 company. The largest payer was Kyowa Kirin, Inc. with $3,410.
| Company | Payments | Amount |
|---|---|---|
| Kyowa Kirin, Inc. 4151.T | 2 | $3,410 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.